These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23591601)

  • 1. Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012.
    Fitch KD
    Br J Sports Med; 2013 Sep; 47(13):815-8. PubMed ID: 23591601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.
    Vernec A; Healy D
    Br J Sports Med; 2020 Aug; 54(15):920-924. PubMed ID: 32376674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Use Exemptions.
    Gerrard D; Pipe A
    Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of therapeutic use exemptions at the Olympic Games and Paralympic Games: an analysis of data from 2016 to 2022.
    Vernec A; Healy D; Banon T; Petroczi A
    Br J Sports Med; 2024 Sep; 58(17):966-972. PubMed ID: 38981660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Use Exemptions (TUEs) are essential in sport: but there is room for improvement.
    Fitch K
    Br J Sports Med; 2020 Feb; 54(3):191-192. PubMed ID: 31000565
    [No Abstract]   [Full Text] [Related]  

  • 8. World anti-doping regulations for 2005: essential changes for athletes and physicians.
    Pabinger C; Gruber G
    Arch Orthop Trauma Surg; 2006 May; 126(4):286-8. PubMed ID: 16333634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.
    Stuart M; Kwon YI; Rhie SJ
    Br J Sports Med; 2019 Sep; 53(17):1105-1110. PubMed ID: 30894336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interview: partnering with the industry: the Olympic laboratory model.
    Cowan DA; Barker CP
    Bioanalysis; 2012 Jul; 4(13):1545-8. PubMed ID: 22831471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.
    Fitch K
    Clin Med (Lond); 2012 Jun; 12(3):257-60. PubMed ID: 22783779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta2-Agonists at the Olympic Games.
    Fitch KD
    Clin Rev Allergy Immunol; 2006; 31(2-3):259-68. PubMed ID: 17085798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.
    Smith R; Barnsley L; Kannangara S; Mace A
    Rheumatology (Oxford); 2004 Dec; 43(12):1473-5. PubMed ID: 15292526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER; Kim TY
    Uisahak; 2014 Aug; 23(2):269-318. PubMed ID: 25223222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it legal? Prescribing for the athlete.
    Sando BG
    Aust Fam Physician; 1999 Jun; 28(6):549-53. PubMed ID: 10399386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medicolegal aspects of doping in sports].
    Pruvost J; Depiesse F
    Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History of mass spectrometry at the Olympic Games.
    Hemmersbach P
    J Mass Spectrom; 2008 Jul; 43(7):839-53. PubMed ID: 18570181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene doping.
    Haisma HJ; de Hon O
    Int J Sports Med; 2006 Apr; 27(4):257-66. PubMed ID: 16572366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.